Page 6 - Presentation
P. 6
Learning Objectives
By the end of this program, participants will be able to:
• Assess and recognize patients with metastatic castration-sensitive prostate cancer
(mCSPC), non-metastatic castration-resistant prostate cancer (nmCRPC), and
metastatic castration-resistant prostate cancer (mCRPC) who require an intensification
or change in their treatment strategy
• Integrate recent Canadian guidance for the management of advanced prostate cancer
into routine practice
• Facilitate patient referral from community practices to tertiary centres as appropriate for
patients with advanced disease to access the appropriate therapies and services
7 7 7